Selected publications

  1. Morosi L, Meroni M, Ubezio P, Fuso Nerini I, Minoli L, Porcu L, Panini N, Colombo M, Blouw B, Kang DW, Davoli E, Zucchetti M, D’Incalci M, Frapolli R.
    PEGylated recombinant human hyaluronidase (PEGPH20) pre-treatment improves intra-tumour distribution and efficacy of paclitaxel in preclinical models (2021) J Exp Clin Cancer Res, 10;40(1):286.
  2. Morosi, L., Matteo, C., Ceruti, T., Giordano, S., Ponzo, M., Frapolli, R., Zucchetti, M., Davoli, E., D’incalci, M., Ubezio, P.
    Quantitative determination of niraparib and olaparib tumor distribution by mass spectrometry imaging (2020) International Journal of Biological Sciences, 16 (8), pp. 1363-1375.
  3. Capasso Palmiero, U., Morosi, L., Bello, E., Ponzo, M., Frapolli, R., Matteo, C., Ferrari, M., Zucchetti, M., Minoli, L., De Maglie, M., Romanelli, P., Morbidelli, M., D’Incalci, M., Moscatelli, D.
    Readily prepared biodegradable nanoparticles to formulate poorly water soluble drugs improving their pharmacological properties: The example of trabectedin (2018) Journal of Controlled Release, 276, pp. 140-149.
  4. Morosi, L., Giordano, S., Falcetta, F., Frapolli, R., Licandro, S.A., Matteo, C., Zucchetti, M., Ubezio, P., Erba, E., Visentin, S., D’Incalci, M., Davoli, E.
    Application of 3D Mass Spectrometry Imaging to TKIs (2017) Clinical Pharmacology and Therapeutics, 102 (5), pp. 748-751.
  5. Maiolo D, Pigliacelli C, Sánchez Moreno P, Violatto MB, Talamini L, Tirotta I, Piccirillo R, Zucchetti M, Morosi L, Frapolli R, Candiani G, Bigini P, Metrangolo P, Baldelli Bombelli F.
    Bioreducible Hydrophobin-Stabilized Supraparticles for Selective Intracellular Release (2017) ACS Nano. 26;11(9):9413-9423.
  6. Giordano S, Zucchetti M, Decio A, Cesca M, Fuso Nerini I, Maiezza M, Ferrari M, Licandro SA, Frapolli R, Giavazzi R, Maurizio D, Davoli E, Morosi L.
    Heterogeneity of paclitaxel distribution in different tumor models assessed by MALDI mass spectrometry imaging.. (2016) Sci Rep. 6:39284.
  7. Ansaloni, L., Coccolini, F., Morosi, L., Ballerini, A., Ceresoli, M., Grosso, G., Bertoli, P., Busci, L.M., Lotti, M., Cambria, F., Pisano, M., Rossetti, D., Frigerio, L., D’Incalci, M., Zucchetti, M.
    Pharmacokinetics of concomitant cisplatin and paclitaxel administered by hyperthermic intraperitoneal chemotherapy to patients with peritoneal carcinomatosis from epithelial ovarian cancer (2015) British Journal of Cancer, 112 (2), pp. 306-312.
  8. Cesca, M., Morosi, L., Berndt, A., Fuso Nerini, I., Frapolli, R., Richter, P., Decio, A., Dirsch, O., Micotti, E., Giordano, S., D’Incalci, M., Davoli, E., Zucchetti, M., Giavazzi, R.
    Bevacizumab-induced inhibition of angiogenesis promotes a more homogeneous intratumoral distribution of paclitaxel, improving the antitumor response (2016) Molecular Cancer Therapeutics, 15 (1), pp. 125-135.